Study of GS-4528 in Adults With Solid Tumors
NCT05840224
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
182
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
BIOLOGICAL:
GS-4528
DRUG:
Zimberelimab
Sponsor
Gilead Sciences